University of Michigan Medical Center, Ann
Arbor, Mich;
6 Beth Israel Deaconess Medical Center, Boston, Mass
Objective: Using a national data set, we sought to describe the population of patients for and the nature and timing of reinterventions after thoracic endovascular aortic repair (TEVAR) by aortic disease as well as by the impact on survival.
Methods: We evaluated the national data set for TEVAR in the Vascular Quality Initiative from 2010 to 2017. Student t-test and c 2 analysis were used to compare continuous and categorical variables in the reintervention and no reintervention groups, respectively. Freedom from reintervention and survival analysis was performed using Kaplan-Meier methods.
Results: A total of 6170 patients were evaluated: 51.2%, thoracic aortic aneurysm; 33.5%, type B dissection (TBD); 6.7%, trauma; 7.0%, penetrating aortic ulcer; and 1.6%, intramural hematoma. Overall, 477 (7.73%) underwent at least one reintervention, with an in-hospital reintervention rate of 3.29%. Reintervention patients were younger (64.4 6 14.5 vs 66.0 6 14.5 years; P ¼ .022) and more often transferred (37.7% vs 29.6%; P < .001), urgent (41.5% vs 33.6%; P ¼ .01), hypertensive (87.6% vs 83.8%; P ¼ .030), anticoagulated (14.0% vs 10.1%; P ¼ .007), symptomatic (54.3% vs 48.7%; P < .001), and ruptured (10.2% vs 6.5%; P < .001). In addition, the reintervention group exhibited more complexity with greater contrast material volume (130 6 81 vs 113 676 mL; P < .001), estimated blood loss (318 6 606 vs 281 6 517 mL; P ¼ .142), procedure time (183.5 6 128.0 vs 170.4 6 112.7 minutes; P ¼ .016), arm/neck access (28.9% vs 20.3%; P < .001), proximal deployment zones 0 to 2 (41.5% vs 16.9; P < .001), and larger mean proximal graft diameter (36.0 6 4.2 mm vs 34.1 6 5.4 mm; P ¼ .002). The reintervention group had more complicated postoperative courses marked by longer intensive care unit stays (6.5 6 7.4 vs 4.2 6 6.3 days; P < .001), total length of stay (16.1 6 35.0 vs 10.1 6 22.8 days; P < .001), more packed red blood cells (2.1 6 3.8 vs 1.2 6 3.1 units; P < .001), and vasopressor use (35.4% vs 23.8%; P < .001). Reinterventions were most commonly performed for TBD (12.4%), with reinterventions for other diseases occurring at lower rates: thoracic aortic aneurysm, 6.0%; intramural hematoma, 4.9%; penetrating aortic ulcer, 4.3%; and trauma, 1.7%. The most common cause of reintervention across all aortic diseases was type I endoleak. Other causes for reintervention by aortic disease are listed in the Table. Freedom from reintervention was decreased for TBD compared with other diseases (P < .001; Fig) . Whereas patients requiring in-hospital reinterventions suffered from increased mortality (P ¼ .05), there was no difference in survival in comparing patients undergoing reinterventions with those without (P ¼ .80).
Conclusions: Whereas reinterventions were not rare after TEVAR, there was no difference in mortality between patients undergoing reintervention and those without. Patients undergoing TEVAR for TBD demonstrated the highest reintervention rate. This study highlights the importance of long-term follow-up to address disease-specific patterns of reintervention.
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Type Objective: A potential correlation between the indication for low-profile endograft implantation and the incidence of type II endoleaks (T2ELs) after endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms has been postulated. The aim of this study was to report the immediate and midterm incidence and fate of T2ELs in an unselected population of patients treated by EVAR using the Ovation stent graft (Endologix, Irvine, Calif).
Methods: A retrospective study was conducted in three high-volume Italian vascular centers including 261 consecutive elective patients. Outcome measures were intraprocedural, immediate (30-day), 12-month, and midterm T2EL incidence and its related reintervention rate. At preoperative computed tomography angiography, mean common iliac artery and external iliac artery (EIA) diameter, EIA stenosis (>70%), EIA diameter #5 mm, and iliac tortuosity ratio #0.5 were noted and considered markers of severely diseased vessels and independent factors potentially influencing outcome. Equal end points and anatomic characteristics were evaluated on a control group consisting of the last 150 patients treated by conventional endografts (Excluder; W. L. Gore & Associates, Flagstaff, Ariz) at one of the involved centers.
Results: There were 214 male patients (81.9%); mean age was 75.93 6 8.65 years. Mean preoperative abdominal aortic aneurysm diameter was 57.15 6 8.77 mm. Mean common iliac artery and EIA diameters were 12.02 mm and 8.01 mm, respectively; 119 (%) patients presented with an EIA #5 mm, 24 bilateral. EIA stenosis >70% was present in 18 patients (6.9%). Iliac tortuosity ratio #0.5 was present in 38 patients (14.6%). Technical success was achieved in all cases, and 57 T2ELs were evident (21.8%) at completion angiography. No further procedures were performed. At 30-day and 12-month follow-up, both reintervention and mortality rates were null; T2EL was evident in 33 (12.6%) and 29 (11.1%) patients, respectively. Mean follow-up time was 30.14 6 18.46 months (range, 1-70 months). T2EL was still evident in 24 (9.1%) patients, and 3 of them required reintervention. All treated patients were submitted to translumbar embolization with satisfactory immediate results. Regarding anatomic preoperative characteristics considered as potentially influencing outcome, in no case was a statistically significant difference observed between patients presenting or not with T2EL (P > .05 for all variables). Gore-treated patients were less likely to have severely diseased access vessels (Table) . T2EL incidence at 30-day follow-up computed tomography angiography was no different with respect to the Ovationtreated group (14.6% vs 12.6%; P ¼ .561; odds ratio, 1.18; 95% confidence interval, 0.66-2.12).
Conclusions: Our initial experience suggests that EVAR by Ovation stent graft does not increase the incidence of T2EL compared with standard devices, even in patients with complex iliac access vessels. Objective: The objective of this study was to analyze the anatomic characteristics of arch aneurysms in the Japanese population and to evaluate the feasibility of four next-generation stent grafts with branched or fenestrated configuration.
Methods: Consecutive arch aneurysm patients receiving either total arch replacement or thoracic endovascular aortic repair (TEVAR) that necessitated zone 0 or 1 proximal landing from 2007 to 2017 in a Japanese hospital were analyzed. Patients with ruptured aneurysm, anastomotic aneurysm, traumatic aneurysm, dissection at the landing zone, previous TEVAR or thoracic aortic replacement, and inadequate preoperative computed tomography angiograms were excluded. All measurements were performed using centerline of flow technique on the three-dimensional workstation. Outer curvature of aorta was measured for the aortic length. The anatomic feasibility of TAG Thoracic Branch Endoprosthesis (W. L. Gore & Associates, Flagstaff, Ariz), Zenith A-branch (Cook Medical, Bloomington, Ind), Relay Branch (Bolton Medical, Sunrise, Fla), and Najuta (Kawasumi Laboratories, Inc, Tokyo, Japan) were evaluated using the instructions for use (IFU) currently proposed by the manufacturer.
Results: During the study period, 178 arch aneurysms (mean maximum aneurysm diameter, 62.1 6 11.5 mm) were identified to be eligible for the study (84.3% male; mean age, 74.6 6 7.2 years; mean height, 161.8 6 7.6 cm; mean body weight, 61.7 6 10.8 kg; Table) . Mean length from sinotubular junction to brachiocephalic artery (BCA) and BCA to left common carotid artery (CCA) was 114.3 6 14.9 mm and 12.5 6 5.5 mm, respectively. Mean aortic diameter at sinotubular junction, BCA, and left CCA was 31.4 6 3.5 mm, 34.1 6 5.4 mm, and 33.8 6 7.1 mm, respectively. Mean BCA length, BCA diameter, and left CCA diameter were 40.9 6 7.7 mm, 13.2 6 2.1 cm, and 7.0 6 1.4 mm, respectively. For the feasibility study, 
